Arcadia Biosciences (NASDAQ:RKDA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Arcadia Biosciences beat estimated earnings by 41.18%, reporting an EPS of $-0.2 versus an estimate of $-0.34.
Revenue was up $2.39 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.12 which was followed by a 25.93% drop in the share price the next day.
Here's a look at Arcadia Biosciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.30 | -0.29 | -0.27 | -0.30 |
| EPS Actual | -0.42 | -0.15 | -0.24 | 0.11 |
| Revenue Estimate | 3.33M | 2.51M | 1.71M | 850.00K |
| Revenue Actual | 2.17M | 2.38M | 1.41M | 828.00K |
To track all earnings releases for Arcadia Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
